Key result
COVID-19 pandemic linked to ~24% higher in-hospital mortality and more AMI discharges among diabetic adults.
Why the study?
The COVID-19 pandemic disrupted cardiovascular care delivery, but comprehensive evaluations of diabetes-AMI outcomes across diverse sociodemographics remain limited.
How did the COVID-19 pandemic and sociodemographic factors affect AMI discharges and in-hospital mortality among adults with diabetes?
Cohort
Yes
How did the COVID-19 pandemic and sociodemographic factors affect AMI discharges and in-hospital mortality among adults with diabetes?
Answers are grounded in this paper and cite their sources.
The COVID-19 pandemic significantly increased AMI admissions and in-hospital mortality among diabetic patients in California, exposing profound sociodemographic disparities across age, race, geography, and insurance status.
Introduction and Objective: Diabetes mellitus increases the risk of acute myocardial infarction (AMI) and associated mortality. The COVID-19 pandemic disrupted cardiovascular care delivery; however, comprehensive evaluations of diabetes-AMI outcomes across diverse sociodemographics remain limited. To (i) examine temporal trends in AMI discharges and in-hospital mortality among adults with diabetes in California from 2016-2022; (ii) assess sociodemographic disparities; and (iii) quantify relative inequalities across age, race/ethnicity, insurance, and geography. Methods: Population-based retrospective cohort analysis using California hospital discharge data (2016-2022) for all adults (≥18 years) hospitalized with concurrent diabetes mellitus and AMI. Multivariable logistic regression estimated adjusted odds ratios (aOR) with 95% confidence intervals. Results: Discharges increased 34.8-46.5% during COVID-19 era versus 7.1-20.0% pre-pandemic. In-hospital mortality peaked with a 24.4% increase in 2022. Age showed the largest disparities (8.27-fold discharges increase in very old adults) with 80.7% attenuation to mortality. Asian populations demonstrated consistent dual elevation: discharges (+29.7%) and mortality (+21.1%) vs White populations. Geographic clustering identified Sacramento (+48.6% discharges), and Los Angeles and Inland Empire (+49.5% and +46.9% mortality) as highest affected regions when compared with Central and Coast regions. Private insurance showed paradoxical effects: +19.0% admissions but -7.8% mortality versus Medi-Cal. Conclusion: The COVID-19 pandemic substantially increased diabetes-AMI burden across multiple domains. Increased age represents the dominant non-modifiable disparity and insurance status represents the most-modifiable factor with disparities. Race and geographic location are likely surrogates for complex socioeconomic disparities that will need additional studies.
No takes yet. Share an insight, caveat, or question.
RATNASIRI et al. (2026) conducted a cohort in Acute myocardial infarction with concurrent diabetes mellitus. COVID-19 pandemic vs. Pre-pandemic period was evaluated on AMI discharges and in-hospital mortality. The COVID-19 pandemic increased AMI discharges by 34.8-46.5% and peaked in-hospital mortality by 24.4% among hospitalized adults with diabetes in California.
Synapse has enriched 10 related papers. Consider them for comparative context: